Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06445816
Other study ID # Istanbul Gelisim Üniversity
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date May 1, 2023
Est. completion date July 1, 2024

Study information

Verified date June 2024
Source Istanbul Gelisim University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Resilience is defined as generating coping strategies for the problems and situations that individuals face throughout their lives and developing these strategies in each new situation. While some individuals become helpless in the face of difficulties and give up the struggle, other individuals recover quickly in the face of difficulties and use coping methods well. Accordingly, these individuals have higher levels of crisis management and coping with stress.


Description:

Psychological resilience is defined as the process of adaptation, the power of recovery or the ability to successfully overcome change/disasters against significant sources of stress such as a trauma, a threat, a tragedy or family and relational distress, serious health problems, workplace and financial problems. At the same time, psychological resilience, as a personality trait, is also used to mean the power to recover quickly, the power to overcome difficulties, resilience, flexibility and robustness. Individuals who are successful in repairing the psychological destruction that occurs as a result of negative emotional states are considered to be strong individuals in terms of psychological resilience. Identification of protective factors Psychological resilience is a dynamic process resulting from the interaction of risk factors and protective factors. In the literature, the most frequently emphasized characteristics when defining psychological resilience are risk factors, protective factors that mitigate the impact of negative events and adaptation to risk factors. Personal risk factors include anxious temperament, health problems, lack of self-confidence, inability to use effective coping mechanisms, inability to express oneself effectively, aggressive personality, pessimistic perspective. Familial risk factors include lack of healthy family relationships, domestic violence, loss of parents, neglect and abuse in the family, and negative relationships. Environmental risk factors include low socio-economic level, lack of positive role models, unemployment and migration. Protective factors are situations that increase the individual's adaptation to all risk factors and improve the individual's competencies. In other words, they are factors that reduce or eliminate the negative effects of risk factors. In research, risk factors and protective factors are analyzed in three stages: individual, familial and environmental It is stated that individuals with high levels of psychological resilience have a higher level of control over their behaviors compared to other individuals, believe that they can achieve higher success as a result of their efforts, have better social competence and responsibilities, and are more successful in solving problems. When we look at other characteristics of individuals with high psychological resilience, it is stated that they have the power and resilience to influence the people around them and to take advantage of upsetting events and to achieve results. It has also been found that individuals with high levels of resilience have high levels of self-confidence and less anxiety. These individuals like to struggle and do not like to give up. Individuals with low levels of psychological resilience have poor self-control capacity, withdraw from the environment, do not participate in social life and show resistance to change. Individuals with good resilience prefer to struggle by questioning their lives.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 50
Est. completion date July 1, 2024
Est. primary completion date July 1, 2024
Accepts healthy volunteers No
Gender All
Age group 4 Years to 17 Years
Eligibility Inclusion Criteria: - Children will be between 4-18 years old - Communicable children and families - The child will be hospitalized for inpatient treatment Exclusion Criteria: - Outpatients - Terminal patients - Children whose parents cannot be reached will be excluded from work

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
chemotherapy
Parents whose consent was obtained will be asked to fill out the Mother and Child Information Collection Form and Psychological Resilience Scale, respectively. Immediately after receiving chemotherapy, the pain levels of the children will be measured with the Facial Expressions Pain Scale - Faces Pain Scale-Revised (FPS-R). The psychological resilience scale will be applied to mothers.

Locations

Country Name City State
Turkey Istanbul Gelisim University Istanbul Avcilar

Sponsors (1)

Lead Sponsor Collaborator
Istanbul Gelisim University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Psychological resilience scale The pain level of the child receiving chemotherapy will reduce the psychological resilience of the mother. In the schematic evaluation, the scoring method is free for measuring psychological resilience as high or low. 2 day
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Terminated NCT04356352 - Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain Phase 2/Phase 3
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04466111 - Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05868122 - A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy Phase 3
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Enrolling by invitation NCT06087432 - Is PNF Application Effective on Temporomandibular Dysfunction N/A
Completed NCT05508594 - Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 Phase 2/Phase 3
Recruiting NCT03646955 - Partial Breast Versus no Irradiation for Women With Early Breast Cancer N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT02913027 - Can We Improve the Comfort of Pelvic Exams? N/A
Terminated NCT02181387 - Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor? Phase 4
Recruiting NCT06032559 - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment Phase 3
Active, not recruiting NCT03613155 - Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care